- Home
- REXR vs SNN Comparison
REXR vs SNN Comparison
Compare REXR & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REXR
- SNN
- Stock Information
- Founded
- REXR 2013
- SNN 1856
- Country
- REXR United States
- SNN United Kingdom
- Employees
- REXR N/A
- SNN N/A
- Industry
- REXR Real Estate Investment Trusts
- SNN Industrial Specialties
- Sector
- REXR Real Estate
- SNN Health Care
- Exchange
- REXR Nasdaq
- SNN Nasdaq
- Market Cap
- REXR 10.2B
- SNN 15.2B
- IPO Year
- REXR 2013
- SNN 1999
- Fundamental
- Price
- REXR $40.98
- SNN $36.45
- Analyst Decision
- REXR Hold
- SNN Hold
- Analyst Count
- REXR 11
- SNN 4
- Target Price
- REXR $42.70
- SNN $33.50
- AVG Volume (30 Days)
- REXR 2.2M
- SNN 586.2K
- Earning Date
- REXR 10-15-2025
- SNN 10-30-2025
- Dividend Yield
- REXR 4.17%
- SNN 2.05%
- EPS Growth
- REXR 15.85
- SNN 59.91
- EPS
- REXR 1.43
- SNN 0.56
- Revenue
- REXR $997,931,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- REXR $8.18
- SNN $7.75
- Revenue Next Year
- REXR $4.05
- SNN $5.40
- P/E Ratio
- REXR $28.98
- SNN $64.09
- Revenue Growth
- REXR 10.40
- SNN 5.35
- 52 Week Low
- REXR $29.68
- SNN $23.69
- 52 Week High
- REXR $44.72
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- REXR 43.35
- SNN 52.77
- Support Level
- REXR $42.15
- SNN $35.74
- Resistance Level
- REXR $44.38
- SNN $37.51
- Average True Range (ATR)
- REXR 0.84
- SNN 0.43
- MACD
- REXR -0.24
- SNN 0.02
- Stochastic Oscillator
- REXR 20.19
- SNN 62.41
About REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.